An internal standard for the quantification of C18 ganglioside GD2
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

C18 Ganglioside GD2-d7 (d18:1/18:0-d7) (ammonium salt, synthetic)

Item No. 43375

Product Insert (PDF)
Technical Information
Formal Name
N-[(1S,2R,3E)-1-[[[O-(N-acetyl-α-neuraminosyl)-(2→8)-O-(N-acetyl-α-neuraminosyl)-(2→3)-O-[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1→4)]-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-octadecanamide-16,16,17,17,18,18,18-d7, diammonium salt
Synonyms
  • C18 Disialolactosylceramide-d7
  • N-omega-CD7-Octadecanoyl Disaloganglioside GD2
Molecular Formula
C78H129D7N4O34 • 2NH4
Formula Weight
1717.1
Purity
≥99% deuterated forms (d1 -d7)
Formulation
A solution in methanol
Solubility(Learn about Variance in Solubility)
Methanol: Sparingly soluble: 1-10 mg/ml
SMILES
O[C@@H]1[C@@H](O)[C@H](OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(CCCCCCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)O[C@H](CO)[C@@]1([H])O[C@@H]2O[C@H](CO)[C@H](O[C@@]3([H])[C@H](NC(C)=O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)[C@H](O[C@@]4(C([O-])=O)O[C@]([C@H](O)[C@@H](CO)O[C@@]5(C([O-])=O)O[C@]([C@H](O)[C@H](O)CO)([H])[C@H](NC(C)=O)[C@@H](O)C5)([H])[C@H](NC(C)=O)[C@@H](O)C4)[C@H]2O.[NH4+].[NH4+]
InChi Code
InChI=1S/C78H138N4O34.2H3N/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-56(95)82-47(48(91)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2)43-107-73-65(101)64(100)67(54(41-86)109-73)111-74-66(102)71(68(55(42-87)110-74)112-72-59(81-46(5)90)63(99)61(97)52(39-84)108-72)116-78(76(105)106)37-50(93)58(80-45(4)89)70(115-78)62(98)53(40-85)113-77(75(103)104)36-49(92)57(79-44(3)88)69(114-77)60(96)51(94)38-83;;/h32,34,47-55,57-74,83-87,91-94,96-102H,6-31,33,35-43H2,1-5H3,(H,79,88)(H,80,89)(H,81,90)(H,82,95)(H,103,104)(H,105,106);2*1H3/b34-32+;;/t47-,48+,49-,50-,51+,52+,53+,54+,55+,57+,58+,59+,60+,61-,62+,63+,64+,65+,66+,67+,68-,69+,70+,71+,72-,73+,74-,77+,78-;;/m0../s1/i1D3,6D2,8D2;;
InChi Key
YRCWXRNEIKSMEW-IWVVMWGOSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    100 µg

    $273

    Add

    250 µg

    $648

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    C18 Ganglioside GD2-d7 (d18:1/18:0-d7) is intended for use as an internal standard for the quantification of C18 ganglioside GD2 by GC- or LC-MS. C18 Ganglioside GD2 is a ganglioside containing stearic acid (Item No. 10011298) as the acyl chain. Plasma levels of C18 ganglioside GD2 are increased in patients with neuroblastoma.1 This product is fully synthetic and has no variations in the fatty acyl chain or sphingoid backbone.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Morini, M., Barco, S., Ardito, M., et al. Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluation. Oncologist 30(2), oyaf008 (2025).